AbbVie has received US FDA approval for Emblaveo to be used in conjunction with metronidazole for individuals with cIAI.

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

NHS England appeals for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) ...

SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

The NHS rolled out the first ever routine vaccination programme this winter, with estimates suggesting it could prevent up to ...

The NHS is urging around 1.3 million older people who have not yet had the respiratory syncytial virus vaccine to get jabbed, as health service chiefs warn it is “not just a winter illness”. Invites ...

Health officials have warned that people need to be protected against respiratory syncytial virus (RSV) by the vaccine.

The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years.

While RSV infections are common and not usually serious, adults over the age of 75, babies under six months and people with a weakened immune system can become severely ill. The virus can lead to ...

The condition of the sole Guillain-Barré Syndrome (GBS) patient in Mumbai, who is undergoing treatment in civic-run Seven ...